Preparation and properties in vitro and in vivo of antitubercular pyrroles

Journal of Heterocyclic Chemistry

Volumn 47, Issue 3, 2010, Pages 707-712

  Hearn, Michael J ^a   Chen, Michaeline F ^a   Terrot, Marianne S ^a   Webster, Eleanor R ^a   Cynamon, Michael H ^b  

^a WELLESLEY COLLEGE   (United States)

^b SYRACUSE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOSALICYLOYL)AMINO 2,5 DIMETHYLPYRROLE; 1 (4 BROMOBENZOYL)AMINO 2,5 DIMETHYLPYRROLE; 1 (4 CHLOROBENZOYL)AMINO 2,5 DIMETHYLPYRROLE; 1 (4 NITROBENZOYL)AMINO 2,5 DIMETHYLPYRROLE; 1 (4 PYRIDOYL)AMINO 2,5 DIMETHYLPYRROLE; 1 (4 TOLUOYL)AMINO 2,5 DIMETHYLPYRROLE; 1 BENZOYLAMINO 2,5 DIMETHYLPYRROLE; ALCOHOL; HYDRAZIDE DERIVATIVE; ISONIAZID; PYRROLE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTITUBERCULAR ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CHEMICAL REACTION; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROMETRY; TUBERCULOSIS;

EID: 77952985516     PISSN: 0022152X     EISSN: 19435193     Source Type: Journal    
DOI: 10.1002/jhet.352     Document Type: Article

References (37)

1. Di Perri, G.; Bonora, S. J Antimicrob Chemother 2004, 54, 593.
2. World Health Organization. TB: A global emergency; Geneva, Switzerland, 1994; Report No. 14977.
3. Hampton, T. JAMA 2004, 291, 2529.
4. Global Alliance for Tuberculosis Drug Development. Scientific blueprint for TB drug development, 2001. Available at: www.tballiance.org/downloads/ publications/TBA-Scientific-Blueprint.pdf. Accessed July 6, 2009.
5. Cahn, P.; Perez, H.; Ben, G.; Ochoa, C. J Int Assoc Physicians AIDS Care 2003, 2, 106.
6. Laughon, B. Curr Topics Med Chem 2007, 7, 463.
7. Barry, C. E. Issues Infect Dis 2003, 2, 137.
8. Davies, P.; Yew, W. Expert Opin Ther Targets 2003, 12, 1297.
9. Miesel, L.; Rozwarski, D.; Sacchettini, J.; Jacobs, W. In Genetics and Tuberculosis, Novartis Foundation Symposia; Chadwick, D. J., Ed.; Wiley: Chichester, England, 1998; pp 209-227.
10. Billington, D.; Coleman, M.; Ibiabuo, J.; Lambert, P.; Rathbone, D.; Tims, K. Drug Des Discov 1998, 15, 269.
11. Pathak, A.; Pathak, V.; Seitz, L.; Suling, W.; Reynolds, R. J Med Chem 2004, 47, 273.
12. Janin, Y. Bioorg Med Chem 2007, 15, 2479.
13. de Souza, M.; Pais, K.; Kaiser, C.; Peralta, M.; Ferreira, M. L.; Lourenço, M. C. S. Bioorg Med Chem 2009, 17, 1474.
14. Hearn, M. J.; Webster, E. R.; Cynamon, M. H. J Heterocycl Chem 2005, 42, 1225.
15. Hearn, M. J.; Chanyaputhipong, P. J Heterocycl Chem 1995, 32, 1647.
16. Youmans, G.; Doub, L.; Youmans, A. The Bacteriostatic Activity of 3500 Organic Compounds for Mycobacterium tuberculosis var. hominis; Chemical-Biological Coordination Center, National Research Council: Washington, DC, 1953; compound 2603.
17. Cymerman-Craig, J.; Willis, D. J Chem Soc 1955, 4315.
18. Gazave, J.; Buu-Hoi, N.; Xuong, N.; Mallet, J.; Pillot, J.; Savel, J.; Dufraisse, G. Therapie 1957, 12, 486.
19. Yale, H.; Losee, K.; Martins, J.; Holsing, M.; Perry, F.; Bernstein, J. J Am Chem Soc 1953, 75, 1933.
20. Zsolnai, T. Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheit und Hygiene, Abteilung 1: Medizinisch-Hygienische Bakteriologie, Virusforschung und Parasitologie, Orginale 1959, 175, 269.
21. Hearn, M. J.; Terrot, M. S. Abstracts of Papers, American Chemical Society 221st National Meeting, San Diego, California, 2001, CHED-156.
22. Bijev, A. Arzneimittelforschung 2009, 59, 34.
23. Arora, S.; Sinha, N.; Sinha, R.; Uppadhayaya, R.; Modak, V.; Tilekar, A. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2004; Abstract Number F-1115.
24. Biava, M.; Porretta, G. C.; Poce, G.; Logu, A. D.; Saddi, M.; Meleddu, R.; Manetti, F.; Rossi, E. D.; Botta, M. J Med Chem 2008, 51, 3644.
25. Biava, M.; Porretta, G. C.; Poce, G.; Supino, S.; Deidda, D.; Pompei, R.; Molicotti, P.; Manetti, F.; Botta, M. J Med Chem 2006, 49, 4946.
26. Paal-Knorr Synthesis. In The Organic Chemistry Portal, 2009. Available at: www.organic-chemistry.org/namedreactions/paal-knorr-pyrrole-synthesis.shtm. Accessed July 31, 2009.
27. Bellina, F.; Rossi, R. Tetrahedron 2006, 62, 7213.
28. Buu-Hoi, N.; Xuong, N. J Org Chem 1955, 20, 850.
29. Banik, B.; Samajdar, S.; Banik, I. J Org Chem 2004, 69, 213.
30. Just, P. E.; Chane-Ching, K. I.; Lacaze, P. C. Tetrahedron 2002, 58, 3467.
31. Global Alliance for Tuberculosis Drug Development.Tuberculosis 2008, 88, 85.
32. Shoen, C.; DeStefano, M.; Sklaney, M.; Monica, B.; Slee, A.; Cynamon, M. J Antimicrob Chemother 2004, 53, 641.
33. Vestal, A. L. Procedures for the Isolation and Identification of Mycobacteria; Laboratory Division, National Communicable Disease Center, Public Health Service: Atlanta, Georgia, 1969; publication number 1995, pp 113-115.
34. Wong, C. S.; Palmer, G. S.; Cynamon, M. H. J Antimicrob Chemother 1988, 22, 863.
35. Secrist, J.; Anathan, S.; Kwong, C.; Maddry, J.; Reynolds, R.; Poffenberger, A.; Michael, M.; Miller, L.; Krahenbuhl, J.; Adams, L.; Biswas, A.; Franzblau, S.; Rouse, D.; Winfield, D.; Brooks, J.; Orme, I. Antimicrob Agents Chemother 2001, 45, 1943.
36. Amarnath, V.; Amarnath, K.; Valentine, W.; Eng, M.; Graham, D. Chem Res Toxicol 1995, 8, 234.
37. Hearn, M. J.; Chen, M. F.; Cynamon, M. H.; Wang'ondu, R.; Webster, E. R. J Sulfur Chem 2006, 27, 149.